Technology Beacon Therapeutics releases 12-Month Data from Phase 2 SKYLINE Trial of AGTC-501 for patients with X-linked retinitis pigmentosa
Technology In the Pipeline: Watermark Leasing New California Project; Ohio Lifeplan Community Plans Active Adult